WIN-Partners Co., Ltd.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from WIN-Partners Co., Ltd.'s yearly results (2023–2026), compared with Healthcare companies in Japan. Tap ? on any ratio for what it means.
What stands out
- Self-Funding Ratio: Over the last 3 years its own operating cash covered its investment spending (capex) 6.7 times. Higher than 94% of Healthcare companies in Japan.
- Cash Cushion Ratio: Cash, after subtracting all debt, equals 45% of its market value (net cash). Higher than 90% of Healthcare companies in Japan.
Cash quality
Profit Cash Ratio
¥134Over the last 3 years, every ¥100 of reported profit came with ¥134 of operating cash.
Higher than 53% of Healthcare companies in Japan.
Self-Funding Ratio
6.7×Over the last 3 years its own operating cash covered its investment spending (capex) 6.7 times.
Higher than 94% of Healthcare companies in Japan.
Cash Locked Ratio
¥2For every ¥100 of sales, ¥2 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against ¥2 tied up three years earlier.
Less money tied up than 77% of Healthcare companies in Japan.
Growth quality
Steadiness Ratio
3/3 · 2/3Sales grew in 3 of the last 3 years; profit grew in 2 of 3.
Steadier than 71% of Healthcare companies in Japan.
Growth Efficiency Ratio
¥0Sales grew 28% in 3 years; of every extra ¥100 of sales, ¥0 became extra profit.
Lower than 67% of Healthcare companies in Japan.
Asset Productivity Ratio
+28% / +15%In 3 years sales changed by +28% while total assets changed by +15%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
—Data incomplete
Cash Cushion Ratio
+45%Cash, after subtracting all debt, equals 45% of its market value (net cash).
Higher than 90% of Healthcare companies in Japan.
Tangible Assets Ratio
98%Of every ¥100 the company owns, ¥98 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 60% of Healthcare companies in Japan.
Tangible Net Worth Ratio
96%Of every ¥100 of net worth, ¥96 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
More tangible than 55% of Healthcare companies in Japan.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (13)
WIN-Partners Co., Ltd. owes ¥0.54 for every ¥1 it owns. Net profit rose 5% in the year to Mar 2026, and grew 1% a year on average over 3 years.
Compared with Healthcare companies in Japan · latest annual results Mar 2026.
P/E ratio
17.0Investors pay ¥17.0 for every ¥1 of WIN-Partners Co., Ltd.'s yearly profit, higher than 54% of Healthcare companies in Japan.
P/B ratio
1.44The share price is 1.44 times WIN-Partners Co., Ltd.'s book value per share, lower than 56% of Healthcare companies in Japan.
Market cap
¥33.5 BThe total market value of all of WIN-Partners Co., Ltd.'s shares at today's price (share price × number of shares), larger than 59% of Healthcare companies in Japan. PosiCap size class: Mini Cap.
Net worth (book value)
¥23.3 BWhat WIN-Partners Co., Ltd. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (31 Mar 2026).
Book value per share
¥846.95Net worth divided by the number of shares. The share price of ¥1,219 is 1.4 times this, which is the P/B above.
Return on equity (ROE)
9.2%WIN-Partners Co., Ltd. earned 9.2% on its shareholders' money over the last year, higher than 61% of Healthcare companies in Japan.
Owes vs Owns
0.54×WIN-Partners Co., Ltd. owes ¥0.54 for every ¥1 it owns (moderate), higher than 68% of Healthcare companies in Japan.
Dividend yield
4.47%WIN-Partners Co., Ltd. pays 4.47% of its share price as dividends a year, higher than 93% of dividend-paying Healthcare companies in Japan.
Revenue growth
+11%Revenue rose 11% in the year to Mar 2026, and grew 8% a year on average over 3 years.
Profit growth
+5%Net profit rose 5% in the year to Mar 2026, and grew 1% a year on average over 3 years.
Profit margin
2.3%WIN-Partners Co., Ltd. keeps ¥2 of every ¥100 of revenue as net profit.
Cash quality
1.4×Cash from WIN-Partners Co., Ltd.'s business was 1.4× its reported profit in the year to Mar 2026 — its profit turned into cash.
Cash vs debt
Net cashWIN-Partners Co., Ltd. held ¥15.2 B more cash than debt (net cash) at Mar 2026.
Questions
What is WIN-Partners Co., Ltd.'s P/E ratio?
Investors pay ¥17.0 for every ¥1 of WIN-Partners Co., Ltd.'s yearly profit, higher than 54% of Healthcare companies in Japan.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For WIN-Partners Co., Ltd.: ¥33.5 B ÷ ¥23.3 B (31 Mar 2026) = 1.4.
What is WIN-Partners Co., Ltd.'s return on equity?
WIN-Partners Co., Ltd. earned 9.2% on its shareholders' money over the last year, higher than 61% of Healthcare companies in Japan.
How much does WIN-Partners Co., Ltd. owe compared with what it owns?
WIN-Partners Co., Ltd. owes ¥0.54 for every ¥1 it owns (moderate), higher than 68% of Healthcare companies in Japan.
Does WIN-Partners Co., Ltd. pay a dividend?
Yes. WIN-Partners Co., Ltd. pays 4.47% of its share price as dividends a year, higher than 93% of dividend-paying Healthcare companies in Japan.
Is WIN-Partners Co., Ltd.'s revenue growing?
Revenue rose 11% in the year to Mar 2026, and grew 8% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.